[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608968":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":18,"responsibleParty":96,"collaborators":11,"id":98,"slug":99,"hasResults":100,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":11,"eligibilityCriteria":104,"healthyVolunteers":100,"sex":105,"minAge":106,"maxAge":11,"enrollmentInfo":107,"targetDuration":11,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":11,"overallStatus":21,"whyStopped":11,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},{"fullName":5,"class":6},"Voll Medical Technologies Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Voll Degradable Shoulder Spacer","EXPERIMENTAL",null,[13],"Device: Voll Degradable Shoulder Spacer",[15],{"type":16,"name":9,"description":9,"armGroupLabels":17,"otherNames":11},"DEVICE",[9],[19,43,59,79],{"facility":20,"status":21,"city":22,"state":11,"zip":11,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Assuta Ashdod Hospital","RECRUITING","Ashdod","Israel","IL",{"type":26,"coordinates":27},"Point",[28,29],34.64966,31.79213,{"lat":29,"lon":28},[32,37,40],{"name":33,"role":34,"phone":35,"phoneExt":11,"email":36},"Sahar Boostenay","CONTACT","+97254421243","sahar@vollmedical.com",{"name":38,"role":39,"phone":11,"phoneExt":11,"email":11},"Ran Atzmon, MD","PRINCIPAL_INVESTIGATOR",{"name":41,"role":42,"phone":11,"phoneExt":11,"email":11},"Yariv Goldstein, MD","SUB_INVESTIGATOR",{"facility":44,"status":45,"city":46,"state":11,"zip":11,"country":23,"countryCode":24,"cosmosGeoPoint":47,"geoPoint":51,"contacts":52},"Ichilov (Sourasky Medical Center)","NOT_YET_RECRUITING","Tel Aviv",{"type":26,"coordinates":48},[49,50],34.78057,32.08088,{"lat":50,"lon":49},[53,55,57],{"name":33,"role":34,"phone":54,"phoneExt":11,"email":36},"+972544621243",{"name":56,"role":39,"phone":11,"phoneExt":11,"email":11},"Efi Kazum, MD",{"name":58,"role":42,"phone":11,"phoneExt":11,"email":11},"Eran Maman, MD",{"facility":60,"status":45,"city":61,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Humanitas Gavazzeni Castelli","Bergamo","24125","Italy","IT",{"type":26,"coordinates":66},[67,68],9.66721,45.69601,{"lat":68,"lon":67},[71,73,75,77],{"name":33,"role":34,"phone":54,"phoneExt":11,"email":72},"saharb@vollmedical.com",{"name":74,"role":39,"phone":11,"phoneExt":11,"email":11},"Vincenzo Condello, MD",{"name":76,"role":42,"phone":11,"phoneExt":11,"email":11},"Vincenzo Madonna, MD",{"name":78,"role":42,"phone":11,"phoneExt":11,"email":11},"Marco Collarile, MD",{"facility":80,"status":21,"city":81,"state":81,"zip":82,"country":63,"countryCode":64,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Istituto Ortopedico Rizzoli","Bologna","40136",{"type":26,"coordinates":84},[85,86],11.33875,44.49381,{"lat":86,"lon":85},[89,90,92,94],{"name":33,"role":34,"phone":54,"phoneExt":11,"email":72},{"name":91,"role":39,"phone":11,"phoneExt":11,"email":11},"Stefano Zaffagnini, Prof.",{"name":93,"role":42,"phone":11,"phoneExt":11,"email":11},"Federico Coliva, MD",{"name":95,"role":42,"phone":11,"phoneExt":11,"email":11},"Vitogaetano Rinaldi, MD",{"type":97,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100608968","voll-degradable-shoulder-spacer-fih-study-100608968",false,"NCT07208448","Voll Degradable Shoulder Spacer FIH Study","A Multi-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears","Main Inclusion Criteria:\n\n* Full thickness MRCT.\n* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.\n\nMain Exclusion Criteria:\n\n* Documented evidence of a history of drug\u002Falcohol abuse within 1 year of enrollment.\n* Concurrent participation in any other investigational clinical study.","ALL","50 Years",{"count":108,"type":109},20,"ESTIMATED","INTERVENTIONAL",[112],"NA","The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).",[115],"Massive Rotator Cuff Tear","2026-03-05",{"date":118,"type":119},"2026-03-06","ACTUAL",{"date":121,"type":119},"2025-12-09",{"date":123,"type":109},"2027-12-31",{"name":5,"class":6},4]